Suppr超能文献

[局部地塞米松治疗对小鼠角膜抗原呈递细胞的影响]

[Effect of topical dexamethasone treatment on antigen-presenting cells in murine corneas].

作者信息

Müller A, Zhang E P, Hoffmann F

机构信息

Augenklinik, Universitätsklinikum Benjamin Franklin der FU Berlin.

出版信息

Ophthalmologe. 2003 Apr;100(4):310-3. doi: 10.1007/s00347-002-0728-4.

Abstract

OBJECTIVE

To determine the influence of dexamethasone treatment on APCs and the time of graft survival of MHC-disparate grafts.

METHODS

Flatmounts of the ocular surface prepared with EDTA and tangential frozen sections of the remaining corneal stroma from untreated eyes of normal mice (n=6) and from eyes treated for 7 days with dexamethasone ( n=6) were immunohistologically examined for content of F4/80+ and MHC II+ cells.Furthermore, corneas of C(3)H mice without and with 7-day dexamethasone eye drop treatment (n=8) were grafted into BALB/c mice receiving the same treatment.

RESULTS

The number of positive cells within the epithelial flatmounts showed a dramatic reduction in the dexamethasone-pretreated group (p<0.01 compared to the untreated control group). The number of positive cells in the corneal stroma remained unchanged. The grafts of untreated control mice survived 16+/-4 days, the treated grafts 16+/-3 days.

CONCLUSIONS

Most investigators assume that normal murine corneas contain no APCs such as macrophages and Langerhans cells. For the first time we were able to detect APCs in flatmounts of the ocular surface and frozen sections of corneal stroma. Our investigations show that, in contrast to the ocular surface, the number of F4/80+ cells in the corneal stroma is not influenced by dexamethasone treatment. Transplantation of corneas containing donor-derived APCs promotes acute rejection (direct pathway of allorecognition).Thus,dexamethasone treatment did not prolong the time of allograft survival.

摘要

目的

确定地塞米松治疗对抗原呈递细胞(APCs)以及主要组织相容性复合体(MHC)不相合移植物存活时间的影响。

方法

对正常小鼠未处理眼(n = 6)和经地塞米松处理7天的眼(n = 6),用乙二胺四乙酸(EDTA)制备眼表平铺片,对剩余角膜基质进行切向冰冻切片,进行免疫组织学检查,以检测F4/80+和MHC II+细胞的含量。此外,将未接受地塞米松滴眼液治疗和接受7天地塞米松滴眼液治疗的C(3)H小鼠角膜(n = 8)移植到接受相同治疗的BALB/c小鼠体内。

结果

地塞米松预处理组上皮平铺片中阳性细胞数量显著减少(与未处理对照组相比,p<0.01)。角膜基质中阳性细胞数量保持不变。未处理对照小鼠的移植物存活16±4天,处理后的移植物存活16±3天。

结论

大多数研究者认为正常小鼠角膜不含巨噬细胞和朗格汉斯细胞等抗原呈递细胞。我们首次能够在眼表平铺片和角膜基质冰冻切片中检测到抗原呈递细胞。我们的研究表明,与眼表不同,角膜基质中F4/80+细胞的数量不受地塞米松治疗的影响。含有供体来源抗原呈递细胞的角膜移植会促进急性排斥反应(同种异体识别的直接途径)。因此,地塞米松治疗并未延长同种异体移植物的存活时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验